BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1413 related articles for article (PubMed ID: 23850875)

  • 1. Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
    Manesis EK; Vourli G; Dalekos G; Vasiliadis T; Manolaki N; Hounta A; Koutsounas S; Vafiadis I; Nikolopoulou G; Giannoulis G; Germanidis G; Papatheodoridis G; Touloumi G
    J Hepatol; 2013 Nov; 59(5):949-56. PubMed ID: 23850875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis delta in HIV-infected individuals in Europe.
    Soriano V; Grint D; d'Arminio Monforte A; Horban A; Leen C; Poveda E; Antunes F; de Wit S; Lundgren J; Rockstroh J; Peters L
    AIDS; 2011 Oct; 25(16):1987-92. PubMed ID: 21857493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis B and hepatitis D coinfection in asymptomatic blood donors in Iran.
    Attaran MS; Sharifi Z; Hosseini SM; Samei S; Ataee Z
    APMIS; 2014 Mar; 122(3):243-7. PubMed ID: 23879563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
    Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
    J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea.
    Kim HS; Kim SJ; Park HW; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Med Virol; 2011 Jul; 83(7):1172-7. PubMed ID: 21541950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.
    Ho E; Deltenre P; Nkuize M; Delwaide J; Colle I; Michielsen P;
    J Med Virol; 2013 Sep; 85(9):1513-7. PubMed ID: 23852675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status.
    Nicolini LA; Taramasso L; Schiavetti I; Giannini EG; Beltrame A; Feasi M; Cassola G; Grasso A; Bartolacci V; Sticchi L; Picciotto A; Viscoli C;
    Antivir Ther; 2015; 20(2):193-7. PubMed ID: 24963642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization.
    Keshvari M; Alavian SM; Aghaee B; Behnava B; Mahdavi M; Fesharaki MG; Sharafi H
    Transfus Med; 2014 Dec; 24(6):411-7. PubMed ID: 25523297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
    Heidrich B; Serrano BC; Idilman R; Kabaçam G; Bremer B; Raupach R; Önder FO; Deterding K; Zacher BJ; Taranta A; Bozkaya H; Zachou K; Tillmann HL; Bozdayi AM; Manns MP; Yurdaydın C; Wedemeyer H
    Liver Int; 2012 Oct; 32(9):1415-25. PubMed ID: 22716112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing hepatitis D virus epidemiology in a hepatitis B virus endemic area with a national vaccination program.
    Lin HH; Lee SS; Yu ML; Chang TT; Su CW; Hu BS; Chen YS; Huang CK; Lai CH; Lin JN; Wu JC
    Hepatology; 2015 Jun; 61(6):1870-9. PubMed ID: 25677884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China.
    Liao B; Zhang F; Lin S; He H; Liu Y; Zhang J; Xu Y; Yi J; Chen Y; Liu H; Wang Z; Cai W
    PLoS One; 2014; 9(12):e115888. PubMed ID: 25532128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
    Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR
    Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
    Makhlouf NA; Morsy KH; Mahmoud AA
    J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virological and clinical characteristics of delta hepatitis in Central Europe.
    Heidrich B; Deterding K; Tillmann HL; Raupach R; Manns MP; Wedemeyer H
    J Viral Hepat; 2009 Dec; 16(12):883-94. PubMed ID: 19566789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
    Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
    J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.